You are currently viewing a new version of our website. To view the old version click .
  • Indexed inScopus
  • 21 daysTime to First Decision

Onco, Volume 5, Issue 4

December 2025 - 9 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (9)

  • Article
  • Open Access
93 Views
10 Pages

Targeted Biological Therapy and Germline Mutation Prevalence in Advanced Ovarian Cancer Patients

  • Anne-Marie Mosbæk Ellegaard,
  • Tim Svenstrup Poulsen and
  • Estrid Høgdall

16 December 2025

Background: Ovarian cancer is one of the most lethal gynecological malignancies, often diagnosed at an advanced stage. The prognosis is generally poor, with high recurrence rates and limited long-term survival. Understanding the genetic and molecular...

  • Review
  • Open Access
685 Views
18 Pages

23 November 2025

Hematological malignancies such as acute myeloid leukemia (AML), chronic myeloid leukemia (CML), lymphomas, and multiple myeloma remain difficult to model ex vivo because conventional two-dimensional (2D) cultures and murine systems fail to reproduce...

  • Article
  • Open Access
1 Citations
633 Views
28 Pages

18 November 2025

Background: Colorectal cancer (CRC) is a major contributor to cancer-related mortality globally. Despite significant advances in therapeutic strategies, CRC continues to exhibit high recurrence rates. This underscores the urgent need for reliable, no...

  • Review
  • Open Access
748 Views
30 Pages

Transcription Factors as Drivers of Gallbladder Cancer: Mechanisms, Dysregulation, and Therapeutic Prospects

  • Sunanda Kulshrestha,
  • Sabuj Samaddar,
  • Anshika Singh,
  • Kunal Yadav,
  • Deepanshu Aul,
  • Tulika Singh,
  • Sonika Kumari Sharma and
  • Samarendra Kumar Singh

10 November 2025

Gallbladder cancer (GBC), an aggressive malignancy of the biliary tract, is characterized by pronounced geographical variation and a poor prognosis, with a five-year survival rate below 20%. Despite its low global incidence, it ranks as the fifth mos...

  • Review
  • Open Access
1,630 Views
16 Pages

The Role of Metabolic Inflammation and Insulin Resistance in Obesity-Associated Carcinogenesis–A Narrative Review

  • Ademar Dantas da Cunha Junior,
  • Larissa Ariel Oliveira Carrilho,
  • Paulo Ricardo Santos Nunes Filho,
  • Luca Cantini,
  • Laura Vidal,
  • Maria Carolina Santos Mendes,
  • José Barreto Campello Carvalheira and
  • Kamal S. Saini

27 October 2025

The inflammatory milieu surrounding tumors plays a pivotal yet paradoxical role in promoting carcinogenesis. Rather than simply acting as a host defense mechanism, chronic low-grade inflammation actively nurtures tumor development and supports hallma...

  • Review
  • Open Access
794 Views
16 Pages

Preoperative Assessment of Surgical Resectability in Ovarian Cancer Using Ultrasound: A Narrative Review Based on the ISAAC Trial

  • Juan Luis Alcázar,
  • Cristian Morales,
  • Carolina Venturo,
  • Florencia de la Maza,
  • Laura Lucio,
  • Manuel Lozano,
  • José Carlos Vilches,
  • Rodrigo Orozco and
  • Manuela Ludovisi

16 October 2025

Background: Ovarian cancer remains a major contributor to cancer-related morbidity and mortality worldwide. Primary cytoreductive surgery is the cornerstone of treatment, and accurate preoperative assessment of tumor resectability is critical to guid...

  • Review
  • Open Access
1,642 Views
25 Pages

Integration of Radical Intent Treatment in Colorectal Liver Metastases

  • Francisco J. Pelegrín-Mateo and
  • Javier Gallego Plazas

2 October 2025

Colorectal liver metastases (CRLM) management remains a complex conundrum in the context of potential curable disease. The combination of systemic therapy and surgery, with overall survival outcomes up to 58% at five years, has become the gold standa...

  • Communication
  • Open Access
1 Citations
1,133 Views
7 Pages

Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort

  • Laura Antolino,
  • Germana de Nucci,
  • Stefania Scarpino,
  • Giuseppe Bianco,
  • Gianluca Lopez,
  • Paolo Aurello,
  • Niccolò Petrucciani,
  • Roberto Santoro,
  • Giuseppe Nigri and
  • Salvatore Agnes
  • + 2 authors

24 September 2025

Pancreatic cancer is expected to become the second leading cause of death by 2030 in Western countries. There is a need to pinpoint high-risk populations since extensive screening would be economically impractical. Methods: This study, conducted on l...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Onco - ISSN 2673-7523